Chunyan Xu

1.2k citations
38 papers · 869 indexed · h-index 17
Topics
Cancer Cells and Metastasis (5 papers)Glycosylation and Glycoproteins Research (4 papers)MicroRNA in disease regulation (4 papers)

In The Last Decade

Chunyan Xu

35 papers receiving 854 citations

Peers

Chunyan Xu
Comparison fields: 5 of 94
  • Molecular Biology 499
  • Cancer Research 168
  • Oncology 126
  • Physiology 95
  • Cellular and Molecular Neuroscience 90
Replace Xiang Ren with:
Xiang Ren China
Federica Baldassari Italy
Pan Gao China
Zhihui Zhu China
Birgit Honrath Germany
Hee Sun Byun South Korea
Sylvia Schreiber Switzerland
Xue Sun China
Jennifer Wen United States
Chunyan Xu relative to Xiang Ren China Xiang Ren's profile →
Citations per field
00.5×3.1×
Xiang Ren · 1×
Citations per year

Countries citing papers authored by Chunyan Xu

Since Specialization
Citations

This map shows the geographic impact of Chunyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunyan Xu more than expected).

Fields of papers citing papers by Chunyan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunyan Xu. The network helps show where Chunyan Xu may publish in the future.

Co-authorship network of co-authors of Chunyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunyan Xu. A scholar is included among the top collaborators of Chunyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunyan Xu. Chunyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 13
4 15
5 15
6 21
7
[Down-regulation of sphingosine kinase 1 (SphK1) enhances the chemosensitivity to cisplatin in human colon cancer RKO cells].
4
8 49
9 11
10 20
11 29
12 1
13 19
14 31
15 31
16 21
17 10
18 101
19
Lignocellulose Selectivity Degradation of White Rot Fungi in Bamboo
5
20 42

About Chunyan Xu

Chunyan Xu is a scholar working on Complementary and alternative medicine, Cancer Research and Immunology, having authored 38 papers that have together received 869 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Glycosylation and Glycoproteins Research (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Sensory Systems (72 citations), Cancer Research (168 citations) and Biological Psychiatry (23 citations). Chunyan Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shiquan Liu, Mengbin Qin, Jiean Huang, Yaping Wang, Xinyi Mu, Jin Zeng, Jie Chen, Jun Liu, Chengpeng Li and Lin Tan. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026